Quick Answer
Orchestra BioMed Holdings, Inc. reported Total Assets of $114.86 million for fiscal year 2025.
Orchestra BioMed Holdings, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $114.86M | +50.8% |
| 2024 | $76.17M | -20.0% |
| 2023 | $95.21M | -0.4% |
| 2022 | $95.57M | -40.9% |
| 2021 | $161.82M | -0.2% |
| 2020 | $162.16M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $104.81M | +39.2% | +144.7% |
| June 30, 2025 | $42.83M | -40.8% | -27.5% |
| March 31, 2025 | $59.05M | -28.5% | -22.5% |
| December 31, 2024 | $76.17M | -20.0% | +1.1% |
| September 30, 2024 | $75.32M | -35.3% | +4.1% |
| June 30, 2024 | $72.38M | -42.5% | -12.4% |
| March 31, 2024 | $82.63M | -39.4% | -13.2% |
| December 31, 2023 | $95.21M | -0.4% | -18.2% |
- Orchestra BioMed Holdings, Inc. showed an increase of +50.8% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Orchestra BioMed Holdings, Inc.’s total assets has declined by 29.2% (from $162.16 million to $114.86 million).
- The most recent figure is from Orchestra BioMed Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: